GSK makes $2.2B deal for RAPT and its food allergy candidate
GSK以22亿美元收购RAPT Therapeutics及其食物过敏候选药物

The biopharma industry was hungry for an M&A deal during last week’s JP Morgan Healthcare Conference.
在上周的摩根大通医疗保健大会上，生物制药行业一直翘首以待一笔并购交易。